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Spermatogenesis (production of sperm) takes place in the testis, which is composed of seminiferous 
tubules. Within mammalian seminiferous tubules, there are two cell types: germ cells and 
supporting somatic cells. The somatic cells found inside the tubules are Sertoli cells, and those 
surrounding the tubules are peritubular myoid cells (PTMs). Evidence supports roles for PTMs in 
multiple critical functions, however, almost nothing is known regarding how PTMs are instructed 
to regulate these distinct functions. Recent data from our lab are beginning to shed light on this – 
we made the exciting discovery that expression of the essential ‘KIT protooncogene receptor 
tyrosine kinase’ (KIT) is regulated in PTMs by retinoic acid (RA) signaling. As a morphogen, RA 
signals in discrete portions of the testis to drive germ cell differentiation, and we observed that RA 
dramatically modified the regional expression of KIT. In germ cells, RA upregulated KIT protein 
expression but did the opposite in PTMs; KIT protein was downregulated in PTMs in vivo by 
exogenous RA and upregulated by WIN 18,446/BDAD mediated inhibition of RA synthesis. We 
are currently investigating the extent to which RA regulates the regional and temporal expression 
of KIT in PTMs. We treated mice with WIN 18,446 for ten days and then injected exogenous RA. 
At different time points after RA injection, mice were euthanized and tissues were collected for 
immunostaining to detect KIT in PTMs, which express ‘actin, alpha 2, smooth muscle, aorta’ 
(ACTA2/a-SMA). We next determined the percentages of ACTA2+ PTMs that were KIT+. Our 
preliminary results suggest that numbers of KIT+ PTMs declines drastically, as early as two days 
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Introduction and Literature Review  
Peritubular Myoid Cells:  
Most people dream of having their own children and family. While the process of 
conception is easy for some, for others it is not. According to clinical data, the current natural 
fertility rate for a healthy, fertile 30-year-old woman is only 20%. This is why it is important 
to not only understand how babies are made, but also to uncover the systems that create the 
two main components of making a baby: sperm and eggs. 
Reproduction has and always will be a prevalent topic in science and understanding 
mechanisms guarding reproduction is of the upmost importance. According to clinical data, 
sperm quality has been continuously decreasing for the last 50 years in developing countries. 
Due to these findings, there is a larger emphasis on answering questions about 
spermatogenesis regulation and the importance of somatic cells in development and 
maintenance of the germ line. The goal of this project is to investigate the regulation of a 
specific somatic cell type present in the mammalian testis.  
The mammalian testis contains several somatic cell types including Sertoli cells, 
Leydig cells and peritubular myoid cells. PTMs can be found surrounding the seminiferous 
tubules and have been found in all mammalian species. In rodents, such as rats, mice and 
hamsters, the cells make up a single layer connected by complexes similar to those in 
epithelial cells. Conversely, in humans 
there are several layers of PTMs. These 
cells, regardless of the organism, exhibit 
a flatten shape with a central nucleus 
giving them an appearance to a sunny 
side up egg. They also be identified by 
their actin filament arrangement which 
exhibits a lattice-work pattern in rats and 
mice (Maekawa M. et al.) Interestingly, 
PTMs are the only cell type in the testis 
for which no counterpart has been 
identified in the ovary (Jeanes A. et al.) 
The presence of PTMs in the adult and 
developing mouse testis suggests a 
Figure 1. Structure of Interest. Cartoon representation of a 
seminiferous tubule within the mammalian testis. Displays 
prospermatogonia residing within the tubule and peritubular myoid 




specific function in spermatogenesis. While it has been proposed that PTMs have several 
functions such as providing key paracrine signals for developing germ cells, providing 
structure for the seminiferous, and are thought to contract their cytoskeleton to extrude newly 
produced testicular sperm from the testis, mechanisms regulating these functions are still 
poorly understood (Maekawa M. et al.) 
KIT Protein:  
On other hand, the receptor tyrosine kinase c-Kit (KIT) is a heavily studied stem cell 
factor and is also expressed in PTMs. c-Kit was first discovered in 1986 as a transforming 
gene of Hardy-Zuckerman feline sarcoma virus and has further been cloned and located within 
other species such as mice and human (Besmer et al.) In both species the gene is expressed as 
a single, 5-kb transcript, but it is localized to human chromosome 4 and mouse chromosome 
5 (Yarden et al.) KIT, and its ligand stem cell factor (SCF) are expressed in many tissues of 
the body where they control key cellular functions. These functions include mediating cell 
survival, migration, and proliferation. It has been shown to have increased importance in 
systems such as hematopoiesis, pigmentation, and fertility. Excessive c-Kit signaling has also 
been shown to result in cancers such as leukemia and tumors in the gastrointestinal tract as 
well as in germ cells (Lennartsson et al.) In terms of fertility, c-kit has shown to be essential 
in maintenance of primordial germ cells and is essential for spermatogonial differentiation 
during spermatogenesis (Rossi et al.) 
Retinoic Acid: 
Retinoic acid (RA) is an intermediate compound in the metabolism of vitamin A (Xuan 
et al.) and has been shown to be required for spermatogenesis. In a study by Griswold et. al., 
authors showed that rats deficient in vitamin A experienced a gradual loss in sperm. They also 
showed this could be recovered by giving a pulse of RA (Griswold et al.) The importance of 
RA in the induction of spermatogenesis is believed to be tied to a need for balance in the 
antioxidant defense system in the male reproductive tract and RA levels have been shown to 
increase during four major transitions during spermatogenesis (Malivindi et al, Endo et al.) 
While there have been many studies relating to spermatogonia and RA, there are very few 
looking at how RA interacts with PTMs. From the existing studies, Vernet et. al. suggested 
that PTMs express RA-degrading enzymes, CYP26, that create a catabolic barrier around the 
seminiferous tubules making it unlikely for low doses of RA to enter the tubules. Regardless, 
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none of this accounts for any signaling caused by RA in PTMs. 
Project Overview:  
The goal of this study is to investigate retinoic acid (RA) as a potential regulator of 
protein expression within peritubular myoid cell (PTM) in mice. Specifically, expression and 
signaling involving the ‘KIT protooncogene receptor tyrosine kinase’ (KIT). Within the 
literature, there is little known about how PTMs regulate their functions. Using our system in 
mice we are able to control retinoic acid metabolism and therefore begin to shed light on 
retinoic acid and its potential to regulate PTMs in the developing and adult mouse testis.  
Materials and Methods  
WIN 18,446/BDAD Mouse Treatment:  
WIN 18,466 (also known as BDAD) is an established compound that blocks the 
metabolism of retinoic acid (RA) in the developing testis. We employ this compound to create 
a RA deficient environment. Between the ages of P1 and P14 mice are treated with WIN 
18,446 through oral feeding and are treated by injection at any age past this point.  
One cohort of mice was treated with WIN 18,446 from P1 through P10 to synchronize 
germ cells to undifferentiated spermatogonia. These mice were then given one pulse of RA on 
P11, BDAD was discontinued, and animals were sacrificed on P12, P14, P16, P18, and P20. 
Tissues were collected and prepared for IIF staining. This treatment plan would allow us to 
examine PTMs in an RA-sufficient environment and synchronized testis (Fig. 2). 
  To create an RA-deficient environment to compare to, another cohort of mice was 
treated with daily WIN 18,446 P1 - P10 to establish synchronization and were given RA on 
P11. This cohort continued to receive WIN 18,446 from P12 until day of sacrifice. These 
Figure 2. Retinoic acid sufficient environment treatment plan. A cohort of mice were given daily treatments of 
WIN 18,446 from P1-P10. On P11 one pulse of retinoic acid was given by injection.  
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Adult Mouse Treatment:  
Since we were also interested in how KIT protein levels in PTMs respond to RA in 
adult mice, we established a different treatment plan for adult males. Adult mice were exposed 
to RA for 6, 12, 24, and 48 hours before being sacrificed. This treatment method was used for 
adults because without constant WIN 18,446 treatment since birth there is no way to ensure a 
synchronized testis. Therefore, we decided to examine how PTMs in the adult testis respond to 
a surplus of RA. A vehicle treatment of DMSO was completed on another cohort of mice to 
mimic RA treatment. Those tissues were then collected and prepared for IIF staining. 
IIF Staining and Quantification:  
Testis tissue was dissected and prepared for cryosectioning. They are first fixed in 4% 
PFA overnight, then washed and incubated overnight again in 30% sucrose in 1X PBS. Finally, 
tissues are transferred from 30% sucrose to O.C.T. to be frozen and sectioned at 5um thickness. 
Once the tissues were sectioned, slides were stained using the Protein Tech rabbit ‘actin, alpha 2, 
smooth muscle, aorta’ (ACTA2/a-SMA) at a concentration of 1:250. This was used to visualize 
PTMs. A goat c-KIT antibody by R&D Systems was used at 1:1000 to identify cells expressing 
c-KIT. Lastly all of these slides were co-stained and mounted with DAPI to identify nuclei. 
Images were taken of each age for both RA deficient and RA sufficient neonatal mice as well as 
adult mice treated for RA or DMSO and then quantified using ImageJ to identify the number of 
KIT+ PTMs.  
Figure 3. Retinoic acid deficient environment treatment plan. A cohort of mice were given daily treatments of 
WIN 18,446 from P1-P10. On P11 one pulse of retinoic acid was given by injection. After P11, mice continued 
to receive daily treatments of WIN 18,446 until date of sacrifice. 
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Results  
RA Sufficient Neonatal Mice: 
Analysis of tissue from mice with 
RA sufficient environments found 
significantly higher numbers of 
KIT+ PTMs at P12 when compared 
to just 72 hours after RA injection 
on P14 and P16 (Figure 4C). On 
P12, nearly 75% of PTMs 
expressed KIT protein and by P14 
and P16 this percentage decreased 
to just under 20%. This decrease 
was also present when the number 
of KIT+ PTMs were compared to 
the tubule perimeter (Figure 4D). 
When observing stained tissues for 
KIT, SMA, and DAPI in P9 testis, 
most KIT expression can be seen 
surrounding the tubules where 
PTMs are also located (Figure 4A). 
This is different when looking at the 
same staining on a P14 tissue where 
KIT expression is localized inside 
of the tubules and is being 
expressed in germ cells (Figure 4B). 
These results demonstrate that RA 
plays a role in the expression of KIT 
protein in PTMs, but the next step 
was to determine if continuous 
treatment of WIN 18,446 could 
maintain KIT expression in PTMs 
after exposure to RA.  
 
Figure 4: Daily treatments of neonatal mice with BDAD significantly increases KIT 
expression in PTMs. (A-B) KIT protein expression decreased in PTMs and increases 
in germ cells after administration of RA. Alpha Smooth Muscle Actin (red), KIT 
(green), DAPI (blue). (C) The percentage of KIT+ PTMs were quantified by counting 
the number of SMA+ cells as well as the number of SMA+KIT+ cells. Biological 
replicate n=3. Technical replicate = 100 tubules. (D) The number of KIT+ PTMs were 
also determined by quantifying SMA+KIT+ cells in relation to the perimeter of each 





RA Deficient Neonatal Mice: 
Analysis of tissue from mice in 
RA deficient environments 
found that KIT expression could 
remain localized just outside of 
the tubules through continuous 
treatment of WIN 18,446. This 
can be seen in P14 mice stained 
for KIT, SMA, and DAPI, 
where KIT expression is still 
surrounding the tubules 72 
hours after RA injection on P11 
(Figure 5A). This suggests that 
KIT expression is primarily 
taking place in PTMs. This 
expression pattern is consistent 
through P21 when similar stains 
were conducted (Figure 5B). 
This increased expression in 
PTMs can also be seen in the 
percentage of PTMs that are 
KIT+. On P12, around 80% of 
PTMs express KIT and this 
percentage is maintained 
through P21 (Figure 5C). Given 
that the percentage of KIT+ 
PTMs in RA deficient mice is 
the same as RA sufficient mice, 
it can be concluded that 
continuous treatment of WIN 
18,446 can maintain elevated 
Figure 5: Continuous treatment of young mice with BDAD maintains increased KIT 
expression in PTMs. (A-B) KIT protein expression remained increased even after the 
pulse of RA. Alpha Smooth Muscle Actin (red), KIT (green), DAPI - control (blue). 
(C) The percentage of KIT+ PTMs were quantified by counting the number of SMA+ 
cells as well as the number of SMA+KIT+ cells. Biological replicate n=3. Technical 
replicate = 100 tubules. (D) The number of KIT+ PTMs were also determined by 
quantifying SMA+KIT+ cells in relation to the perimeter of each tubule. Biological 
replicate n=3. Technical replicate = 100 tubules. 
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KIT expression in PTMs after exposure to RA. This conclusion is echoed when looking at the 
number of KIT+ PTMs per tubule perimeter (Figure 5D).  
RA/DMSO Treated Adult Mice: 
Analysis of tissues from adult mice found that regardless of the length of RA treatment, there was 
a decrease in the percentage of KIT+ PTMs when compared to DMSO-treated mice. Control 
DMSO-treated mice displayed that 50% of PTMs expressed KIT protein while mice treated with 
RA for the same amount of time expressed between 20-25%. This conclusion was consistent across 
6,12-,24-, and 48-hour timepoints (Figure 6A). There was also a decrease in the number of KIT+ 
PTMs per tubule perimeter when comparing control DMSO-treated mice to RA-treated mice. This 
decrease was consistent across all time point, but the most drastic occurred at the 24- and 48-hour 
treatments (Figure 6B). From these results it can be concluded that exposure to RA also decreases 
the percentage of KIT+ PTMs and KIT+ PTMs per tubule perimeter in adult mice as well.  
 
Discussion  
After analysis, we can conclude that RA decreases the percentage of KIT+ PTMs in 
neonatal mice. This can be seen mainly by comparing the percentage of KIT+ PTMs after P12 of 
mice in an RA sufficient environment to mice in an RA deficient environment. RA sufficient mice 
contain display around 80% of PTMs being KIT+. This percentage decreases to 20% by P14 and 
doesn’t increase again until P20 when it reaches approximately 45% (Figure 4C). In comparison, 
around 80% of PTMs are KIT+ in RA deficient mice at P12 and this percentage remains elevated 
 
Figure 6: RA decreases percentage of KIT+ PTMs and number of KIT+ PTMs per tubule length regardless of treatment length. 
Tissues were recovered from adult mice treated for 6,12,24, and 48 hours with RA or DMSO. The percentage of KIT+ PTMs were 
quantified by counting the number of SMA+ cells as well as the number of SMA+KIT+ cells. Biological replicate n=3. Technical 
replicate = 100 tubules. The number of KIT+ PTMs were also determined by quantifying SMA+KIT+ cells in relation to the perimeter 
of each tubule. Biological replicate n=3. Technical replicate = 100 tubules. 
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between 60-70% until P21. There is no dramatic decline in KIT+ PTMs like is seen in the RA 
sufficient mice (Figure 5C). This means exposure to RA does in fact decrease KIT expression in 
PTMs in the neonatal mouse testis. This conclusion doesn’t explain how RA regulates KIT protein 
expression and the answer to questions concerning this regulation will take further experiments and 
studies, some of which might include isolating PTMs from mice treated with WIN 18,446 and 
determining if RA regulates PTMs in a similar capacity in vitro or determining with form of KIT 
is expressed in PTMs of the mouse testis.  
In addition, it can be concluded that RA also decreases the percentage of KIT+ PTMs in 
the adult mouse testis. This can be best observed in the quantification of KIT+ PTMs when treated 
with 6-,12-,24-, and 48-hours of RA or DMSO. In mice treated with RA, the percentage of KIT+ 
PTMs remained between 20-25% regardless of the amount of time treated with RA. In comparison, 
DMSO-treated mice displayed between 50-55% of PTMs being KIT+ regardless of the amount of 
time treated with DMSO. This means that even without WIN 18,446 treatment and a 
synchronization of the testis RA decreases the percentage of KIT+ PTMs in the adult mouse testis. 
Once again, this conclusion does not explain how RA regulates KIT protein expression and the 
answer to questions concerning this regulation will take further experiments and studies. Future 
studies might consider treating adult mice with WIN 18,446 to determine if prolonged treatment 
can induce elevated levels of KIT+ PTMs in the unsynchronized adult testis of mice.  
While this study begins to explore how RA regulates KIT expression in PTMs, it does 
highlight the potential RA has as a regulator of PTM function in the testis. Our hope is that 
through future studies we will learn more about regulation of PTM function and how those 
regulators play role in overall spermatogenesis. 
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